Where do new medicines start? They start in the lab, where scientists study the biological mechanisms that contribute to good health or, when they go awry, cause disease. Beaker highlights interesting science, Sanford-Burnham Medical Research Institute and our supporters.
Beaker's Latest Posts
How beta-amyloid plaques are made in individuals with Down syndrome and Alzheimer's pateints.
Breast Cancer Awareness Month
A team of scientists around Sanford-Burnham's Ranjan Perera, Ph.D., has identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients, but not in normal healthy individuals. The study sets the stage for the development of more-sensitive and specific non-invasive tests for prostate cancer than those currently available
The survivin protein may be a new therapeutic target for brain cancer
Three gifted and promising young postdoctoral researchers were presented the prestigious Fishman Fund Award at the annual ceremony on October 2.
Log in to leave a comment